OZURDEX
Google image searchProduct monograph
Active ingredient
dexamethasone, 0.7 MG
DIN: 02363445
Dosage form(s): IMPLANT
Route(s) of administration: INTRAVITREAL
Description: IMPLANT IN SINGLE-USE APPLICATOR. PRESERVATIVE-FREE
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 11-MAR-2024
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01B — ANTIINFLAMMATORY AGENTS (ATC, ATC/DDD)
- S01BA — Corticosteroids, plain (ATC, ATC/DDD)
- S01BA01 — DEXAMETHASONE (ATC/DDD)
Pharmaceutical standard: USP
